Cervical cancer: new paradigms within a holistic care model
Resumen
In this issue of Revista Colombiana de Obstetricia y Ginecología (Colombian Journal of Obstetrics and Gynecology) we present three studies related to cervical cancer. The first refers to patient knowledge and responses when faced with an abnormal cytology result. The second describes the frequency of an atypical squamous cell cytology result that does not rule out a high-grade squamous intraepithelial lesion (ASC-H); and the third describes the quality of life of women diagnosed with cervical cancer. This circumstance has created the opportunity to establish a perspective regarding issues that need to be studied at a local level in order to improve care for the individual patients suffering from this disease and achieve better public health outcomes in this field. Additionally, it has prompted a reflection about the role of general gynaecologists and subspecialists in the prevention, diagnosis and treatment of precancerous lesions of the cervix, as well as of invasive cervical cancer, in order to improve impact indicators for the disease in Colombia.Descargas
Referencias bibliográficas
Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012. Cancer incidence and mortality worldwide: IARC Cancer Base No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer 2013. [Cited 2014 Dec 22]. Available from: http://globocan.iarc.fr
Muñoz N, Bravo LE. Epidemiology of cervical cancer in Colombia. Colomb Med. 2012;43:298-304.
Piñeros M, Gamboa O, Her nández-Suárez G, Pardo C, Bray F. Patterns and trends in cancer mortality in Colombia 1984-2008. Cancer Epidemiol. 2013;37:233-9.
Instituto Nacional de Cancerología. Anuario estadístico 2011. Volumen 9. ISSN: 1909-8995. Bogotá: Milenio Editores e Impresores E.U.; 2014. [Cited 2014 Dec 22]. Available from: http://www.cancer.gov.co//files/libros/archivos/anuario_2011.pdf.
Murillo R, Wiesner C, Cendales R, Piñeros M, Tovar S. Comprehensive evaluation of cervical cancer screening programs: the case of Colombia. Salud Publica Mex. 2011;53:469-77.
Munoz N, Castellsague X, de González AB, Gissmann L. HPV in the etiology of human cancer. Vaccine. 2006;24:S3/1-10.
FUTURE I/II Study Group, Dillner J, Kjaer SK, Wheeler CM, Sigurdsson K, Iversen OE, et al. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cer vical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. BMJ. 2010;341:c3493.
Lehtinen M, Paavonen J, Wheeler CM, Jaisamrarn U, Garland SM, Castellsague X, et al. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol. 2012;13:89-99.
Elfström KM, Dillner J, Arnheim-Dahlström L. Organization and quality of HPV vaccination programs in Europe. Vaccine. 2015;33:1673-81.
Schiffman M, Wentzensen N. Transitioning to a new era in cervical cancer screening. Gynecol Oncol. 2015;136:175-7.
Ronco G, Dillner J, Elfström KM, Tunesi S, Snijders PJ, Arbyn M, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet. 2014;383:524-32.
Lee EJ1, Kang H, Kim DH. A comparative study of laparoscopic radical hysterectomy with radical abdominal hysterectomy for early-stage cervical cancer: a long-term follow-up study. Eur J Obstet Gynecol Reprod Biol. 2011;156:83-6.
Rob L, Skapa P, Robova H. Fertility-sparing surgery in patients with cervical cancer. Lancet Oncol. 2011;12:192-200.
Hwang JH, Yoo HJ, Joo J, Kim S, Lim MC, Song YJ, et al. Learning curve analysis of laparoscopic radical hysterectomy and lymph node dissection in early cervical cancer. Eur J Obstet Gynecol Reprod Biol. 2012;163:219-23.
Lamb BW, Green JS, Benn J, Brown KF, Vincent CA, Sevdalis N. Improving decision making in multidisciplinary tumor boards: prospective longitudinal evaluation of a multicomponent intervention for 1,421 patients. J Am Coll Surg. 2013;217:412-20.
Tewari KS, Sill MWR, Long HJ 3rd, Penson RT, Huang H, Ramondetta LM, et al. Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med. 2014;370:734-43.
Derechos de autor 2015 Revista Colombiana de Obstetricia y Ginecología
Esta obra está bajo licencia internacional Creative Commons Reconocimiento-NoComercial-SinObrasDerivadas 4.0.
